Mechanisms of adaptive angiogenesis to tissue hypoxia (original) (raw)

• Smith LM, Golub AS, Pittman RN (2002) Interstitial PO(2) determination by phosphorescence quenching microscopy. Microcirculation 9(5):389–395
  PubMed Google Scholar
• Matschke K, Pfeiffer S, Mrowietz C et al (2005) Influence of ventricular pacing on myocardial oxygen tension. Microvasc Res 70(1–2):97–101
  PubMed CAS Google Scholar
• Goetze JP, Gore A, Moller CH et al (2004) Acute myocardial hypoxia increases BNP gene expression. Faseb J 18(15):1928–1930
  PubMed CAS Google Scholar
• Maltepe E, Simon MC (1998) Oxygen, genes, and development: an analysis of the role of hypoxic gene regulation during murine vascular development. J Mol Med 76(6):391–401
  PubMed CAS Google Scholar
• Semenza GL (1998) Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8(5):588–594
  PubMed CAS Google Scholar
• Elson DA, Ryan HE, Snow JW et al (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 60(21):6189–6195
  PubMed CAS Google Scholar
• Lee SH, Wolf PL, Escudero R et al (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342(9):626–633
  PubMed CAS Google Scholar
• Kelly BD, Hackett SF, Hirota K et al (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93(11):1074–1081
  PubMed CAS Google Scholar
• Semenza GL (2007) Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 102(4):840–847
  PubMed CAS Google Scholar
• Hirota K, Semenza GL (2006) Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59(1):15–26
  PubMed Google Scholar
• Hickey MM, Simon MC (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76:217–257
  PubMed CAS Google Scholar
• Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9(6):677–684
  PubMed CAS Google Scholar
• Maxwell PH, Ratcliffe PJ (2002) Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13(1):29–37
  PubMed CAS Google Scholar
• Wood SM, Gleadle JM, Pugh CW et al (1996) The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J Biol Chem 271(25):15117–15123
  PubMed CAS Google Scholar
• Wang GL, Jiang BH, Rue EA et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92(12):5510–5514
  PubMed CAS Google Scholar
• Wiesener MS, Turley H, Allen WE et al (1998) Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92(7):2260–2268
  PubMed CAS Google Scholar
• Heidbreder M, Frohlich F, Johren O et al (2003) Hypoxia rapidly activates HIF-3alpha mRNA expression. Faseb J 17(11):1541–1543
  PubMed CAS Google Scholar
• Li QF, Wang XR, Yang YW et al (2006) Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell Res 16(6):548–558
  PubMed CAS Google Scholar
• Pugh CW, O’Rourke JF, Nagao M et al (1997) Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J Biol Chem 272(17):11205–11214
  PubMed CAS Google Scholar
• Reisz-Porszasz S, Probst MR, Fukunaga BN et al (1994) Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol Cell Biol 14(9):6075–6086
  PubMed CAS Google Scholar
• Sekine H, Mimura J, Yamamoto M et al (2006) Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses. J Biol Chem 281(49):37507–37516
  PubMed CAS Google Scholar
• Huang LE, Gu J, Schau M et al (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2–dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95(14):7987–7992
  PubMed CAS Google Scholar
• Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271–275
  PubMed CAS Google Scholar
• Jaakkola P, Mole DR, Tian YM et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292(5516):468–472
  PubMed CAS Google Scholar
• Epstein AC, Gleadle JM, McNeill LA et al (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1):43–54
  PubMed CAS Google Scholar
• Ivan M, Haberberger T, Gervasi DC et al (2002) Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 99(21):13459–13464
  PubMed CAS Google Scholar
• Berra E, Benizri E, Ginouves A et al (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. Embo J 22(16):4082–4090
  PubMed CAS Google Scholar
• Bruick RK, McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294(5545):1337–1340
  PubMed CAS Google Scholar
• O’Rourke JF, Tian YM, Ratcliffe PJ et al (1999) Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J Biol Chem 274(4):2060–2071
  PubMed CAS Google Scholar
• Kallio PJ, Wilson WJ, O’Brien S et al (1999) Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274(10):6519–6525
  PubMed CAS Google Scholar
• Ema M, Taya S, Yokotani N et al (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94(9):4273–4278
  PubMed CAS Google Scholar
• Tian H, McKnight SL, Russell DW (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11(1):72–82
  PubMed CAS Google Scholar
• Bracken CP, Fedele AO, Linke S et al (2006) Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment. J Biol Chem 281(32):22575–22585
  PubMed CAS Google Scholar
• Uchida T, Rossignol F, Matthay MA et al (2004) Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J Biol Chem 279(15):14871–14878
  PubMed CAS Google Scholar
• Takahashi R, Kobayashi C, Kondo Y et al (2004) Subcellular localization and regulation of hypoxia-inducible factor-2alpha in vascular endothelial cells. Biochem Biophys Res Commun 317(1):84–91
  PubMed CAS Google Scholar
• Park SK, Dadak AM, Haase VH et al (2003) Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23(14):4959–4971
  PubMed CAS Google Scholar
• Maynard MA, Qi H, Chung J et al (2003) Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J Biol Chem 278(13):11032–11040
  PubMed CAS Google Scholar
• Hirsila M, Koivunen P, Gunzler V et al (2003) Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278(33):30772–30780
  PubMed Google Scholar
• Makino Y, Uenishi R, Okamoto K et al (2007) Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J Biol Chem 282(19):14073–14082
  PubMed CAS Google Scholar
• Makino Y, Kanopka A, Wilson WJ et al (2002) Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem 277(36):32405–32408
  PubMed CAS Google Scholar
• Makino Y, Cao R, Svensson K et al (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414(6863):550–554
  PubMed CAS Google Scholar
• Mahon PC, Hirota K, Semenza GL (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15(20):2675–2686
  PubMed CAS Google Scholar
• Lando D, Peet DJ, Gorman JJ et al (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16(12):1466–1471
  PubMed CAS Google Scholar
• Ivan M, Kondo K, Yang H et al (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292(5516):464–468
  PubMed CAS Google Scholar
• Masson N, Willam C, Maxwell PH et al (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Embo J 20(18):5197–5206
  PubMed CAS Google Scholar
• Koivunen P, Tiainen P, Hyvarinen J et al (2007) An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha. J Biol Chem 282(42):30544–30552
  PubMed CAS Google Scholar
• Bruick RK (2003) Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 17(21):2614–2623
  PubMed CAS Google Scholar
• Kaelin WG (2005) Proline hydroxylation and gene expression. Annu Rev Biochem 74:115–128
  PubMed CAS Google Scholar
• Schofield CJ, Ratcliffe PJ (2005) Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commun 338(1):617–626
  PubMed CAS Google Scholar
• Fong GH, Takeda K, (2008) Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ doi:10.1038/cdd.2008.10
• Gerald D, Berra E, Frapart YM et al (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118(6):781–794
  PubMed CAS Google Scholar
• Pan Y, Mansfield KD, Bertozzi CC et al (2007) Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 27(3):912–925
  PubMed CAS Google Scholar
• Metzen E, Zhou J, Jelkmann W et al (2003) Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 14(8):3470–3481
  PubMed CAS Google Scholar
• Koivunen P, Hirsila M, Remes AM et al (2007) Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 282(7):4524–4532
  PubMed CAS Google Scholar
• Selak MA, Armour SM, MacKenzie ED et al (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7(1):77–85
  PubMed CAS Google Scholar
• Baek JH, Mahon PC, Oh J et al (2005) OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol Cell 17(4):503–512
  PubMed CAS Google Scholar
• Ozer A, Wu LC, Bruick RK (2005) The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci USA 102(21):7481–7486
  PubMed CAS Google Scholar
• Nakayama K, Frew IJ, Hagensen M et al (2004) Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 117(7):941–952
  PubMed CAS Google Scholar
• Appelhoff RJ, Tian YM, Raval RR et al (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279(37):38458–38465
  PubMed CAS Google Scholar
• Takeda K, Ho VC, Takeda H et al (2006) Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 26(22):8336–8346
  PubMed CAS Google Scholar
• Takeda K, Cowan A, Fong GH (2007) Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116(7):774–781
  PubMed CAS Google Scholar
• del Peso L, Castellanos MC, Temes E et al (2003) The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J Biol Chem 278(49):48690–48695
  PubMed Google Scholar
• Stiehl DP, Wirthner R, Koditz J et al (2006) Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281(33):23482–23491
  PubMed CAS Google Scholar
• Marxsen JH, Stengel P, Doege K et al (2004) Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381(Pt 3):761–767
  PubMed CAS Google Scholar
• Metzen E, Stiehl DP, Doege K et al (2005) Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem J 387(Pt 3):711–717
  PubMed CAS Google Scholar
• D’Angelo G, Duplan E, Boyer N et al (2003) Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem 278(40):38183–38187
  PubMed CAS Google Scholar
• Zhong H, Chiles K, Feldser D et al (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60(6):1541–1545
  PubMed CAS Google Scholar
• Treins C, Giorgetti-Peraldi S, Murdaca J et al (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277(31):27975–27981
  PubMed CAS Google Scholar
• Feldser D, Agani F, Iyer NV et al (1999) Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59(16):3915–3918
  PubMed CAS Google Scholar
• Zelzer E, Levy Y, Kahana C et al (1998) Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. Embo J 17(17):5085–5094
  PubMed CAS Google Scholar
• Laughner E, Taghavi P, Chiles K et al (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21(12):3995–4004
  PubMed CAS Google Scholar
• Richard DE, Berra E, Pouyssegur J (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275(35):26765–26771
  PubMed CAS Google Scholar
• Page EL, Robitaille GA, Pouyssegur J et al (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 277(50):48403–48409
  PubMed CAS Google Scholar
• Thornton RD, Lane P, Borghaei RC et al (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 350(1):307–312
  PubMed CAS Google Scholar
• Sandau KB, Zhou J, Kietzmann T et al (2001) Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J Biol Chem 276(43):39805–39811
  PubMed CAS Google Scholar
• Fukuda R, Hirota K, Fan F et al (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277(41):38205–38211
  PubMed CAS Google Scholar
• Mylonis I, Chachami G, Samiotaki M et al (2006) Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem 281(44):33095–33106
  PubMed CAS Google Scholar
• Gradin K, Takasaki C, Fujii-Kuriyama Y et al (2002) The transcriptional activation function of the HIF-like factor requires phosphorylation at a conserved threonine. J Biol Chem 277(26):23508–23514
  PubMed CAS Google Scholar
• Richard DE, Berra E, Gothie E et al (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274(46):32631–32637
  PubMed CAS Google Scholar
• Arany Z, Huang LE, Eckner R et al (1996) An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93(23):12969–12973
  PubMed CAS Google Scholar
• Ema M, Hirota K, Mimura J et al (1999) Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. Embo J 18(7):1905–1914
  PubMed CAS Google Scholar
• Land SC, Tee AR (2007) Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 282(28):20534–20543
  PubMed CAS Google Scholar
• Freedman SJ, Sun ZY, Kung AL et al (2003) Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol 10(7):504–512
  PubMed CAS Google Scholar
• Blagosklonny MV, An WG, Romanova LY et al (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273(20):11995–11998
  PubMed CAS Google Scholar
• Lisy K, Peet DJ (2008) Turn me on: regulating HIF transcriptional activity. Cell Death Differ. doi:10.1038/sj.cdd.4402315
• Jain S, Maltepe E, Lu MM et al (1998) Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 73(1):117–123
  PubMed CAS Google Scholar
• Compernolle V, Brusselmans K, Acker T et al (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8(7):702–710
  PubMed CAS Google Scholar
• Rankin EB, Biju MP, Liu Q et al (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117(4):1068–1077
  PubMed CAS Google Scholar
• Gruber M, Hu CJ, Johnson RS et al (2007) Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci USA 104(7):2301–2306
  PubMed CAS Google Scholar
• Ravi R, Mookerjee B, Bhujwalla ZM et al (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14(1):34–44
  PubMed CAS Google Scholar
• Pan Y, Oprysko PR, Asham AM et al (2004) p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23(29):4975–4983
  PubMed CAS Google Scholar
• Sano M, Minamino T, Toko H et al (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446(7134):444–448
  PubMed CAS Google Scholar
• Pi X, Garin G, Xie L et al (2005) BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circ Res 96(11):1145–1151
  PubMed CAS Google Scholar
• Cheng J, Kang X, Zhang S et al (2007) SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131(3):584–595
  PubMed CAS Google Scholar
• Chen L, Uchida K, Endler A et al (2007) Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation. J Biol Chem 282(17):12707–12716
  PubMed CAS Google Scholar
• Minchenko A, Caro J, (2000) Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208(1–2):53–62
  PubMed CAS Google Scholar
• Salani D, Taraboletti G, Rosano L et al (2000) Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157(5):1703–1711
  PubMed CAS Google Scholar
• Oikawa M, Abe M, Kurosawa H et al (2001) Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 289(1):39–43
  PubMed CAS Google Scholar
• Phillips RJ, Mestas J, Gharaee-Kermani M et al (2005) Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280(23):22473–22481
  PubMed CAS Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ et al (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858–864
  PubMed CAS Google Scholar
• Zagzag D, Lukyanov Y, Lan L et al (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86(12):1221–1232
  PubMed CAS Google Scholar
• Zagzag D, Krishnamachary B, Yee H et al (2005) Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65(14):6178–6188
  PubMed CAS Google Scholar
• Suzuki A, Kusakai G, Shimojo Y et al (2005) Involvement of transforming growth factor-beta 1 signaling in hypoxia-induced tolerance to glucose starvation. J Biol Chem 280(36):31557–31563
  PubMed CAS Google Scholar
• Green CJ, Lichtlen P, Huynh NT et al (2001) Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61(6):2696–2703
  PubMed CAS Google Scholar
• Yamakawa M, Liu LX, Date T et al (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93(7):664–673
  PubMed CAS Google Scholar
• Khaliq A, Dunk C, Jiang J et al (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab Invest 79(2):151–170
  PubMed CAS Google Scholar
• Yonekura H, Sakurai S, Liu X et al (1999) Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem 274(49):35172–35178
  PubMed CAS Google Scholar
• Nilsson I, Shibuya M, Wennstrom S, (2004) Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res 299(2):476–485
  PubMed CAS Google Scholar
• Willam C, Koehne P, Jurgensen JS et al (2000) Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 87(5):370–377
  PubMed CAS Google Scholar
• Zhang SX, Gozal D, Sachleben LR Jr. et al (2003) Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. Faseb J 17(12):1709–1711
  PubMed CAS Google Scholar
• Elvert G, Kappel A, Heidenreich R et al (2003) Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278(9):7520–7530
  PubMed CAS Google Scholar
• Le Bras A, Lionneton F, Mattot V et al (2007) HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 26(53):7480–7489
  PubMed CAS Google Scholar
• Pichiule P, Chavez JC, LaManna JC (2004) Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279(13):12171–12180
  PubMed CAS Google Scholar
• Okuyama H, Krishnamachary B, Zhou YF et al (2006) Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 281(22):15554–15563
  PubMed CAS Google Scholar
• Li C, Issa R, Kumar P et al (2003) CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116(Pt 13):2677–2685
  PubMed CAS Google Scholar
• Kaidi A, Qualtrough D, Williams AC et al (2006) Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 66(13):6683–6691
  PubMed CAS Google Scholar
• Anelli V, Gault CR, Cheng AB et al (2008) Sphingosine Kinase 1 is up-regulated during hypoxia in U87MG glioma cells: role of hypoxia-inducible factors 1 and 2. J Biol Chem 283(6):3365–3375
  PubMed CAS Google Scholar
• Sodhi CP, Phadke SA, Batlle D et al (2001) Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50(6):1482–1490
  PubMed CAS Google Scholar
• Zhu Y, Denhardt DT, Cao H et al (2005) Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Oncogene 24(43):6555–6563
  PubMed CAS Google Scholar
• Calvani M, Rapisarda A, Uranchimeg B et al (2006) Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107(7):2705–2712
  PubMed CAS Google Scholar
• Kuwabara K, Ogawa S, Matsumoto M et al (1995) Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 92(10):4606–4610
  PubMed CAS Google Scholar
• Carroll VA, Ashcroft M (2006) Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 66(12):6264–6270
  PubMed CAS Google Scholar
• Kim KS, Rajagopal V, Gonsalves C et al (2006) A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 177(10):7211–7224
  PubMed CAS Google Scholar
• Gunaratnam L, Morley M, Franovic A et al (2003) Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J Biol Chem 278(45):44966–44974
  PubMed CAS Google Scholar
• O’Toole EA, van Koningsveld R, Chen M et al (2008) Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 214(1):47–55
  PubMed CAS Google Scholar
• Ikeda E, Achen MG, Breier G et al (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270(34):19761–19766
  PubMed CAS Google Scholar
• Forsythe JA, Jiang BH, Iyer NV et al (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16(9):4604–4613
  PubMed CAS Google Scholar
• Takeda N, Maemura K, Imai Y et al (2004) Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 95(2):146–153
  PubMed CAS Google Scholar
• Gerber HP, Condorelli F, Park J et al (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272(38):23659–23667
  PubMed CAS Google Scholar
• Marti HH, Risau W, (1998) Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 95(26):15809–15814
  PubMed CAS Google Scholar
• Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12(12):5447–5454
  PubMed CAS Google Scholar
• Kertesz N, Wu J, Chen TH et al (2004) The role of erythropoietin in regulating angiogenesis. Dev Biol 276(1):101–110
  PubMed CAS Google Scholar
• Jaquet K, Krause K, Tawakol-Khodai M et al (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64(2):326–333
  PubMed CAS Google Scholar
• Morita M, Ohneda O, Yamashita T et al (2003) HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. Embo J 22(5):1134–1146
  PubMed CAS Google Scholar
• Yu J, deMuinck ED, Zhuang Z et al (2005) Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 102(31):10999–11004
  PubMed CAS Google Scholar
• Coulet F, Nadaud S, Agrapart M et al (2003) Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278(47):46230–46240
  PubMed CAS Google Scholar
• Zhao X, Lu X, Feng Q, (2002) Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am J Physiol Heart Circ Physiol 283(6):H2371–2378
  PubMed CAS Google Scholar
• Kappel A, Ronicke V, Damert A et al (1999) Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93(12):4284–4292
  PubMed CAS Google Scholar
• Duan LJ, Zhang-Benoit Y, Fong GH (2005) Endothelium-intrinsic requirement for Hif-2alpha during vascular development. Circulation 111(17):2227–2232
  PubMed CAS Google Scholar
• Blau HM, Banfi A, (2001) The well-tempered vessel. Nat Med 7(5):532–534
  PubMed CAS Google Scholar
• Kim JW, Gao P, Liu YC et al (2007) Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27(21):7381–7393
  PubMed CAS Google Scholar
• Schmidt D, Textor B, Pein OT et al (2007) Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis. Embo J 26(3):710–719
  PubMed CAS Google Scholar
• Mizukami Y, Jo WS, Duerr EM et al (2005) Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 11(9):992–997
  PubMed CAS Google Scholar
• Cummins EP, Berra E, Comerford KM et al (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 103(48):18154–18159
  PubMed CAS Google Scholar
• Levy NS, Chung S, Furneaux H et al (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273(11):6417–6423
  PubMed CAS Google Scholar
• Stein I, Itin A, Einat P et al (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18(6):3112–3119
  PubMed CAS Google Scholar
• Ozawa K, Kondo T, Hori O et al (2001) Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J Clin Invest 108(1):41–50
  PubMed CAS Google Scholar
• Asikainen TM, Schneider BK, Waleh NS et al (2005) Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung. Proc Natl Acad Sci USA 102(29):10212–10217
  PubMed CAS Google Scholar
• Brogi E, Schatteman G, Wu T et al (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97(2):469–476
  PubMed CAS Google Scholar
• Waltenberger J, Mayr U, Pentz S et al (1996) Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94(7):1647–1654
  PubMed CAS Google Scholar
• LeCouter J, Kowalski J, Foster J et al (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412(6850):877–884
  PubMed CAS Google Scholar
• Namiki A, Brogi E, Kearney M et al (1995) Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270(52):31189–31195
  PubMed CAS Google Scholar
• Murohara T, Witzenbichler B, Spyridopoulos I et al (1999) Role of endothelial nitric oxide synthase in endothelial cell migration. Arteriosclerosis, thrombosis, and vascular biology 19(5):1156–1161
  PubMed CAS Google Scholar
• Phillips PG, Birnby LM, Narendran A, (1995) Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells. Am J Physiol 268(5 Pt 1):L789–800
  PubMed CAS Google Scholar
• Matsushita H, Morishita R, Nata T et al (2000) Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 86(9):974–981
  PubMed CAS Google Scholar
• Stempien-Otero A, Karsan A, Cornejo CJ et al (1999) Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J Biol Chem 274(12):8039–8045
  PubMed CAS Google Scholar
• An WG, Kanekal M, Simon MC et al (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392(6674):405–408
  PubMed CAS Google Scholar
• Dumont DJ, Fong GH, Puri MC et al (1995) Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203(1):80–92
  PubMed CAS Google Scholar
• Damert A, Miquerol L, Gertsenstein M et al (2002) Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 129(8):1881–1892
  PubMed CAS Google Scholar
• Lee S, Chen TT, Barber CL et al (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130(4):691–703
  PubMed CAS Google Scholar
• Schoch HJ, Fischer S, Marti HH (2002) Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125(Pt 11):2549–2557
  PubMed Google Scholar
• Vogel C, Bauer A, Wiesnet M et al (2007) Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol 212(1):236–243
  PubMed CAS Google Scholar
• Loberg RD, Vesely E, Brosius FC III (2002) Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J Biol Chem 277(44):41667–41673
  PubMed CAS Google Scholar
• Lanner MC, Raper M, Pratt WM et al (2005) Heterotrimeric G proteins and the platelet-derived growth factor receptor-beta contribute to hypoxic proliferation of smooth muscle cells. Am J Respir Cell Mol Biol 33(4):412–419
  PubMed CAS Google Scholar
• Sheares KK, Jeffery TK, Long L et al (2004) Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 287(5):L919–927
  CAS Google Scholar
• Schultz K, Fanburg BL, Beasley D (2006) Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 290(6):H2528–2534
  PubMed CAS Google Scholar
• Lehti K, Allen E, Birkedal-Hansen H et al (2005) An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. Genes Dev 19(8):979–991
  PubMed CAS Google Scholar
• Corley KM Taylor CJ, Lilly B (2005) Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells. J Cell Biochem 96(5):971–985
  Google Scholar
• Foo SS, Turner CJ, Adams S et al (2006) Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124(1):161–173
  PubMed CAS Google Scholar
• Liu Y, Wada R, Yamashita T et al (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106(8):951–961
  PubMed CAS Google Scholar
• Allende ML, Yamashita T, Proia RL (2003) G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102(10):3665–3667
  PubMed CAS Google Scholar
• Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104(8):2224–2234
  PubMed CAS Google Scholar
• Burke-Gaffney A, Brooks AV, Bogle RG (2002) Regulation of chemokine expression in atherosclerosis. Vascul Pharmacol 38(5):283–292
  PubMed CAS Google Scholar
• Morimoto H, Takahashi M, Izawa A et al (2006) Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 99(8):891–899
  PubMed CAS Google Scholar
• Heinrich SA, Messingham KA, Gregory MS et al (2003) Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-alpha. Wound Repair Regen 11(2):110–119
  PubMed Google Scholar
• Clinton SK, Underwood R, Hayes L et al (1992) Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 140(2):301–316
  PubMed CAS Google Scholar
• van Weel V, Seghers L, de Vries MR et al (2007) Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia. Arteriosclerosis, Thrombosis, Vasc Biol 27(6):1426–1432
  Google Scholar
• Dvorak HF, Brown LF, Detmar M et al (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146(5):1029–1039
  PubMed CAS Google Scholar
• Khurana R, Moons L, Shafi S et al (2005) Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111(21):2828–2836
  PubMed CAS Google Scholar
• Hiratsuka S, Nakamura K, Iwai S et al (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2(4):289–300
  PubMed CAS Google Scholar
• Arras M, Strasser R, Mohri M et al (1998) Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 93(2):97–107
  PubMed CAS Google Scholar
• Gordon S, Clarke S, Greaves D et al (1995) Molecular immunobiology of macrophages: recent progress. Curr Opin Immunol 7(1):24–33
  PubMed CAS Google Scholar
• Sunderkotter C, Goebeler M, Schulze-Osthoff K et al (1991) Macrophage-derived angiogenesis factors. Pharmacol Ther 51(2):195–216
  PubMed CAS Google Scholar
• Jansen PL, Rosch R, Jansen M et al (2007) Regulation of MMP-2 gene transcription in dermal wounds. J Invest Dermatol 127(7):1762–1767
  PubMed CAS Google Scholar
• Li J, Post M, Volk R et al (2000) PR39, a peptide regulator of angiogenesis. Nat Med 6(1):49–55
  PubMed CAS Google Scholar
• Nanka O, Valasek P, Dvorakova M et al (2006) Experimental hypoxia and embryonic angiogenesis. Dev Dyn 235(3):723–733
  PubMed CAS Google Scholar
• Lee YM, Jeong CH, Koo SY et al (2001) Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 220(2):175–186
  PubMed CAS Google Scholar
• Iyer NV, Kotch LE, Agani F et al (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12(2):149–162
  PubMed CAS Google Scholar
• Ryan HE, Lo J, Johnson RS (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J 17(11):3005–3015
  PubMed CAS Google Scholar
• Maltepe E, Schmidt JV, Baunoch D et al (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386(6623):403–407
  PubMed CAS Google Scholar
• Ramirez-Bergeron DL, Runge A, Adelman DM et al (2006) HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Dev Cell 11(1):81–92
  PubMed CAS Google Scholar
• Peng J, Zhang L, Drysdale L et al (2000) The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA 97(15):8386–8391
  PubMed CAS Google Scholar
• Tian H, Hammer RE, Matsumoto AM et al (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12(21):3320–3324
  PubMed CAS Google Scholar
• Scortegagna M, Ding K, Oktay Y et al (2003) Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 35(4):331–340
  PubMed CAS Google Scholar
• Tang N, Wang L, Esko J et al (2004) Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6(5):485–495
  PubMed CAS Google Scholar
• gLicht AH, Muller-Holtkamp F, Flamme I et al (2006) Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 107(2):584–590
  Google Scholar
• Gnarra JR, Ward JM, Porter FD et al (1997) Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94(17):9102–9107
  PubMed CAS Google Scholar
• Yin Z, Haynie J, Yang X et al (2002) The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci USA 99(16):10488–10493
  PubMed CAS Google Scholar
• Miquerol L, Langille BL, Nagy A (2000) Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127(18):3941–3946
  PubMed CAS Google Scholar
• Haase VH, Glickman JN, Socolovsky M et al (2001) Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 98(4):1583–1588
  PubMed CAS Google Scholar
• Rankin EB, Higgins DF, Walisser JA et al (2005) Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol Cell Biol 25(8):3163–3172
  PubMed CAS Google Scholar
• Kim WY, Safran M, Buckley MR et al (2006) Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. Embo J 25(19):4650–4662
  PubMed CAS Google Scholar
• Vincent KA, Shyu KG, Luo Y et al (2000) Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 102(18):2255–2261
  PubMed CAS Google Scholar
• Pajusola K, Kunnapuu J, Vuorikoski S et al (2005) Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. Faseb J 19(10):1365–1367
  PubMed CAS Google Scholar
• Heinl-Green A, Radke PW, Munkonge FM et al (2005) The efficacy of a ‘master switch gene’ HIF-1alpha in a porcine model of chronic myocardial ischaemia. Eur Heart J 26(13):1327–1332
  PubMed CAS Google Scholar
• Elson DA, Thurston G, Huang LE et al (2001) Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev 15(19):2520–2532
  PubMed CAS Google Scholar
• Aragones J, Schneider M, Van Geyte K et al (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40(2):170–180
  PubMed CAS Google Scholar
• Kotch LE, Iyer NV, Laughner E et al (1999) Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209(2):254–267
  PubMed CAS Google Scholar
• Hirose K, Morita M, Ema M et al (1996) cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol 16(4):1706–1713
  PubMed CAS Google Scholar
• Oosthuyse B, Moons L, Storkebaum E et al (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28(2):131–138
  PubMed CAS Google Scholar
• Thurston G, Suri C, Smith K et al (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science New York NY 286(5449):2511–2514
  CAS Google Scholar
• Leibovich SJ, Ross R, (1975) The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 78(1):71–100
  PubMed CAS Google Scholar
• Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15(11):599–607
  PubMed CAS Google Scholar
• Simpson DM, Ross R (1972) The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest 51(8):2009–2023
  PubMed CAS Google Scholar
• Reichner JS, Albina JE (2004) Determination of the role of hypoxia-inducible factor 1 in wound healing. Methods Enzymol 381:527–538
  PubMed CAS Google Scholar
• Davidson JD, Mustoe TA (2001) Oxygen in wound healing: more than a nutrient. Wound Repair Regen 9(3):175–177
  PubMed CAS Google Scholar
• Trentin D, Hubbell J, Hall H (2005) Non-viral gene delivery for local and controlled DNA release. J Control Release 102(1):263–275
  PubMed CAS Google Scholar
• Warnecke C, Griethe W, Weidemann A et al (2003) Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. Faseb J 17(9):1186–1188
  PubMed CAS Google Scholar
• Willam C, Masson N, Tian YM et al (2002) Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc Natl Acad Sci USA 99(16):10423–10428
  PubMed CAS Google Scholar
• Banai S, Shweiki D, Pinson A et al (1994) Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28(8):1176–1179
  PubMed CAS Google Scholar
• Lee MY, Ju WK, Cha JH et al (1999) Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci Lett 265(2):107–110
  PubMed CAS Google Scholar
• Miraliakbari R, Francalancia NA, Lust RM et al (2000) Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia. Ann Thorac Surg 69(6):1750–1753; discussion 1754
  Google Scholar
• Nahrendorf M, Swirski FK, Aikawa E et al (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204(12):3037–3047
  PubMed CAS Google Scholar
• Koponen JK, Kekarainen T, Heinonen SE et al (2007) Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model. Mol Ther 15(12):2172–2177
  PubMed CAS Google Scholar
• Wu Y, Ip JE, Huang J et al (2006) Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 99(3):315–322
  PubMed CAS Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7(4):430–436
  PubMed CAS Google Scholar
• Grunewald M, Avraham I, Dor Y et al (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175–189
  PubMed CAS Google Scholar
• Huang Y, Hickey RP, Yeh JL et al (2004) Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. Faseb J 18(10):1138–1140
  PubMed CAS Google Scholar
• Shyu KG, Wang MT, Wang BW et al (2002) Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 54(3):576–583
  PubMed CAS Google Scholar
• Patel TH, Kimura H, Weiss CR et al (2005) Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res 68(1):144–154
  PubMed CAS Google Scholar
• Bosch-Marce M, Okuyama H, Wesley JB et al (2007) Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 101(12):1310–1318
  PubMed CAS Google Scholar
• Gray C, Packham IM, Wurmser F et al (2007) Ischemia is not required for arteriogenesis in zebrafish embryos. Arterioscler Thromb Vasc Biol 27(10):2135–2141
  PubMed CAS Google Scholar
• Heil M, Eitenmuller I, Schmitz-Rixen T et al (2006) Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10(1):45–55
  PubMed CAS Google Scholar
• Isner JM (1999) Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation 99(13):1653–1655
  PubMed CAS Google Scholar
• Moulton KS, Vakili K, Zurakowski D et al (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100(8):4736–4741
  PubMed CAS Google Scholar
• Vink A, Schoneveld AH, Lamers D et al (2007) HIF-1alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 195(2):e69–e75
  PubMed CAS Google Scholar
• Reynolds JD (2001) The management of retinopathy of prematurity. Paediatr Drugs 3(4):263–272
  PubMed CAS Google Scholar
• Pe’er J, Shweiki D, Itin A et al (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72(6):638–645
  PubMed CAS Google Scholar
• Pierce EA, Avery RL, Foley ED et al (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92(3):905–909
  PubMed CAS Google Scholar
• Aiello LP, Pierce EA, Foley ED et al (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92(23):10457–10461
  PubMed CAS Google Scholar
• Ozaki H, Yu AY, Della N et al (1999) Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40(1):182–189
  PubMed CAS Google Scholar
• Nakano M, Satoh K, Fukumoto Y et al (2007) Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 100(5):662–669
  PubMed CAS Google Scholar
• Ritter MR, Banin E, Moreno SK et al (2006) Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 116(12):3266–3276
  PubMed CAS Google Scholar
• Chang KH, Chan-Ling T, McFarland EL et al (2007) IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci USA 104(25):10595–10600
  PubMed CAS Google Scholar
• Lofqvist C, Chen J, Connor KM et al (2007) IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci USA 104(25):10589–10594
  PubMed CAS Google Scholar
• Lima e Silva R, Shen J, Hackett SF et al (2007) The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. Faseb J 21(12):3219–3230
  PubMed CAS Google Scholar
• Kuwabara T, Cogan DG (1963) Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69:492–502
  PubMed CAS Google Scholar
• Beltramo E, Berrone E, Giunti S et al (2006) Effects of mechanical stress and high glucose on pericyte proliferation, apoptosis and contractile phenotype. Exp Eye Res 83(4):989–994
  PubMed CAS Google Scholar
• Ejaz S, Chekarova I, Ejaz A et al (2008) Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 10(1):53–63
  PubMed CAS Google Scholar
• Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480–1487
  PubMed CAS Google Scholar
• Wilkinson-Berka JL, Fletcher EL (2004) Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy. Curr Pharm Des 10(27):3313–3330
  PubMed CAS Google Scholar
• Butler JM, Guthrie SM, Koc M et al (2005) SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115(1):86–93
  PubMed CAS Google Scholar
• Peters CL, Morris CJ, Mapp PI et al (2004) The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum 50(1):291–296
  PubMed CAS Google Scholar
• Hitchon C, Wong K, Ma G et al (2002) Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46(10):2587–2597
  PubMed CAS Google Scholar
• Firestein GS (1999) Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest 103(1):3–4
  PubMed CAS Google Scholar
• Vaupel P, Kallinowski F, Okunieff P (1990) Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv Exp Med Biol 277:895–905
  PubMed CAS Google Scholar
• Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449–6465
  PubMed CAS Google Scholar
• Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59(22):5830–5835
  PubMed CAS Google Scholar
• Talks KL, Turley H, Gatter KC et al (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157(2):411–421
  PubMed CAS Google Scholar
• Lim JH, Lee ES, You HJ et al (2004) Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene 23(58):9427–9431
  PubMed CAS Google Scholar
• Blancher C, Moore JW, Robertson N et al (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3’-kinase/Akt signaling pathway. Cancer Res 61(19):7349–7355
  PubMed CAS Google Scholar
• Semenza G (2002) Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64(5–6):993–998
  PubMed CAS Google Scholar
• Bocci G, Man S, Green SK et al (2004) Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. Cancer Res 64(18):6616–6625
  PubMed CAS Google Scholar
• Christensen JG, Vincent PW, Klohs WD et al (2005) Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol Cancer Ther 4(6):938–947
  PubMed CAS Google Scholar
• Le QT, Sutphin PD, Raychaudhuri S et al (2003) Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res 9(1):59–67
  PubMed CAS Google Scholar
• Jain S, Chakraborty G, Bulbule A et al (2007) Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opin Ther Targets 11(1):81–90
  PubMed CAS Google Scholar
• Drevs J, Zirrgiebel U, Schmidt-Gersbach CI et al (2005) Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK):a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. Ann Oncol 16(4):558–565
  PubMed CAS Google Scholar
• Caine GJ, Blann AD, Stonelake PS et al (2003) Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur J Clin Invest 33(10):883–890
  PubMed CAS Google Scholar
• Schliemann C, Bieker R, Thoennissen N et al (2007) Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia 21(9):1901–1906
  PubMed CAS Google Scholar
• Dudek AZ, Mahaseth H (2005) Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Cancer Invest 23(3):193–200
  PubMed CAS Google Scholar
• Wrobel T, Mazur G, Kapelko K et al (2005) Endostatin serum level in acute myeloid leukemia. Neoplasma 52(2):182–184
  PubMed CAS Google Scholar
• Bernardi R, Guernah I, Jin D et al (2006) PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 442(7104):779–785
  PubMed CAS Google Scholar
• Luttun A, Tjwa M, Moons L et al (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8(8):831–840
  PubMed CAS Google Scholar
• Fischer C, Jonckx B, Mazzone M et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463–475
  PubMed CAS Google Scholar
• Fukumura D, Xavier R, Sugiura T et al (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94(6):715–725
  PubMed CAS Google Scholar
• Semenza GL (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14(16):1983–1991
  PubMed CAS Google Scholar
• Lin EY, Li JF, Gnatovskiy L et al (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66(23):11238–11246
  PubMed CAS Google Scholar
• Petit I, Jin D, Rafii S (2007) The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28(7):299–307
  PubMed CAS Google Scholar
• Li B, Sharpe EE, Maupin AB et al (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. Faseb J 20(9):1495–1497
  PubMed CAS Google Scholar
• Grimm C, Wenzel A, Groszer M et al (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8(7):718–724
  PubMed CAS Google Scholar
• Porta C, Subhra Kumar B, Larghi P et al (2007) Tumor promotion by tumor-associated macrophages. Adv Exp Med Biol 604:67–86
  Article PubMed Google Scholar
• Carmeliet P, Dor Y, Herbert JM et al (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394(6692):485–490
  PubMed CAS Google Scholar
• Ryan HE, Poloni M, McNulty W et al (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60(15):4010–4015
  PubMed CAS Google Scholar
• Mizukami Y, Li J, Zhang X et al (2004) Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res 64(5):1765–1772
  PubMed CAS Google Scholar
• Podar K, Anderson KC (2007) Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies. Cell Cycle 6(5):538–542
  PubMed CAS Google Scholar
• Willett CG, Boucher Y, di Tomaso E et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10(2):145–147
  PubMed CAS Google Scholar
• Niethammer AG, Xiang R, Becker JC et al (2002) A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8(12):1369–1375
  PubMed CAS Google Scholar
• Hu CJ, Wang LY, Chodosh LA et al (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23(24):9361–9374
  PubMed CAS Google Scholar
• Kim HJ, Chung H, Yoo YG et al (2007) Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res 5(4):321–329
  PubMed CAS Google Scholar
• Xu Q, Briggs J, Park S et al (2005) Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24(36):5552–5560
  PubMed CAS Google Scholar
• Jung JE, Lee HG, Cho IH et al (2005) STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. Faseb J 19(10):1296–1298
  PubMed CAS Google Scholar
• Pore N, Liu S, Shu HK et al (2004) Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 15(11):4841–4853
  PubMed CAS Google Scholar
• Miki N, Ikuta M, Matsui T, (2004) Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor alpha4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J Biol Chem 279(15):15025–15031
  PubMed CAS Google Scholar
• Bracken CP, Whitelaw ML, Peet DJ (2005) Activity of hypoxia-inducible factor 2alpha is regulated by association with the NF-kappaB essential modulator. J Biol Chem 280(14):14240–14251
  PubMed CAS Google Scholar
• Sanchez-Elsner T, Botella LM, Velasco B et al (2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276(42):38527–38535
  PubMed CAS Google Scholar
• Desbaillets I, Diserens AC, de Tribolet N et al (1999) Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18(7):1447–1456
  PubMed CAS Google Scholar
• Peng ZG, Zhou MY, Huang Y et al (2008) Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha. Oncogene 27(6):839–847
  PubMed CAS Google Scholar
• Mizukami Y, Fujiki K, Duerr EM et al (2006) Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J Biol Chem 281(20):13957–13963
  PubMed CAS Google Scholar
• Sanchez-Elsner T, Ramirez JR, Sanz-Rodriguez F et al (2004) A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol 336(1):9–24
  PubMed CAS Google Scholar